HIMSA Rings in the New Year with Lower Noah ES Prices!

HIMSA is happy to announce that due to a successful 2023, we are now able to offer significant price reductions on a Noah ES yearly subscription.

Soluvos Medical wishes readers all the best in 2024!

Soluvos Medical is proud to announce that their partnership with A.R.C. Laser has now extended to the UK. They have a full team in the UK, available for advice, hires, service and training.

Digital bone conduction hearing glasses

BHM offers comfortable, tried-and-tested hearing solutions with its bone conduction hearing systems.

Recruitment of Sudden Hearing Loss Patients for Clinical Trial: Novel Compound AC102 Outperforms Corticosteroids Preclinically

While corticosteroids are widely used to treat Sudden Sensorineural Hearing Loss (SSNHL), there is still no therapy with proven efficacy and regulatory approval for this debilitating condition.

Step change in care – changing the quality of life and supporting the NHS

Up to 500,000 GP appointments could be saved per annum with patient self-referral to audiology practices - easing pressure on the NHS, according to a new report.

Interacoustics introduces the game-changing Audible Contrast Threshold (ACT™) test

For more than a century, hearing aids have been prescribed based solely on the pure tone audiogram.With the introduction of ACT, Interacoustics goes beyond the audiogram, and is now able to address the number one complaint from people with hearing loss: hearing conversations in noisy situations.

A triple threat: showcasing Peptest at three ENT conferences

BIOHIT HealthCare is thrilled to be attending three prestigious otorhinolaryngology conferences over the next few weeks.

Interacoustics introduces a new diagnostic test at EUHA

Interacoustics is happy to introduce the Audible Contrast Threshold (ACT™) test; a new, diagnostic test to support the number one challenge with hearing loss: difficulty hearing speech in background noise.

MICRONOMIC® III Good things do come in small packages!

Entermed’s budget-friendly Micronomic III is a compact workstation designed to accommodate every ENT surgeons’ basic requirements in tight conditions.

Neuromod Devices’ €30m funding powers Lenire expansion

Neuromod Devices, the global technology business behind scientifically proven tinnitus treatment technology, Lenire, closed €30m funding to expand availability of the groundbreaking tinnitus intervention.

New Widex Study On Fractal Sound Stimulation in Hearing Aids Shows Positive Effects for Tinnitus Treatment and Overall Well-Being

Widex USA Inc. has published preliminary results of an ongoing study that validates the use of fractal sound stimulation, specifically new Widex SoundRelax tones, in treating tinnitus and supporting relaxation, concentration and well-being for all Widex wearers.

Peptest Q&A

Untreated reflux can cause inflammation, scarring, narrowing and precancerous changes in the oesophagus and larynx, and may increase the risk of asthma and sleep apnoea.